Positioning just under the skin S-ICD System avoids many of the complications associated with the conventional implant procedure and long term performance. It is easily placed and removed shortens while shortening the surgical procedure time. It is the first totally subcutaneous implantable defibrillator used to treat SCA. The market launch of is S-ICD System is scheduled to commence this summer in select geographies.
The President and CEO of Cameron Health, Inc. Jay Warren explains, “our goal was to develop a minimally invasive alternative to conventional ICD’s as well as tackle a number of the unmet needs of patients and physicians. We have made a number of significant advances, the foremost being that the Cameron Health S-ICD System obviates the need for transvenous lead placement.”
Commenting on the S-ICD System, Dr. Ian Crozier from ChristChurch in New Zealand said, “This new approach to ICD therapy is better for a significant portion of my ICD patients. The procedure is surgically simple and may reduce or eliminate some of the complexity inherent with transvenous electrodes. For the implanting clinician, not having to wear a protective lead apron to avoid radiation exposure during the procedure was refreshing.”
Darryl Ward, one of the first patients to receive the Cameron Health S-ICD System remarked, “I feel fortunate that this novel technology was available to me because my previous conventional ICD lead was no longer functioning. I just like the idea of nothing needing to be inside my heart anymore.”
